Synerkine Pharma Raises EUR3.3 Million in Series A Financing - Business Wire

Synerkine Pharma Raises EUR3.3 Million in Series A Financing  Business Wire

Synerkine Pharma Raises EUR3.3 Million Series A to advance novel fusion proteins for the treatment of inflammatory, neuropathic & osteoarthritic pain.



Comments

Post a Comment

Popular posts from this blog

What is Ivermectin, the drug Goa will give to all adults to combat Covid-19 - India Today

Image
Despite a raging debate on the efficacy of Ivermectin in treating Covid-19, Goa has decided to administer the anti-parasitic drug to everyone above 18 years in the state, irrespective of symptoms. While the World Health Organisation (WHO) has warned against the general, unchecked use of Ivermectin, a study published in the American Journal of Therapeutics has said that regular use of the drug may significantly reduce the risk of contracting Covid-19. So, should you take Ivermectin? What has the Health Ministry said? What have researchers found about its efficacy? Here is all you need to know about Ivermectin. - What is Ivermectin? - What does the Health Ministry say on Ivermectin's usage? - Why has Goa prescribed Ivermectin for all adults? - What have WHO, other countries said on Ivermectin usage for Covid-19? - What have other researchers found on Ivermectin? - What are the side effects of Ivermectin? What is Ivermectin? Ivermectin is an oral drug used to treat parasitic infectio...
Read more